Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histology”

342 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 342 results

Not applicableNot Yet RecruitingNCT05004792
What this trial is testing

Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial

Who this might be right for
MelanomaPigmented Lesions
Herlev Hospital 258
Testing effectiveness (Phase 2)Study completedNCT01761292
What this trial is testing

Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Italfarmaco 20
Not applicableStudy completedNCT01887171
What this trial is testing

Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

Who this might be right for
Early Allograft DysfunctionIschemic Reperfusion InjuryLiver Transplantation+1 more
Republican Scientific and Practical Center for Organ and Tissue Transplantation 86
Not applicableStudy completedNCT02144311
What this trial is testing

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 26
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Not applicableUnknownNCT04957446
What this trial is testing

Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic)

Who this might be right for
Nasolabial FoldFacial Wrinkles
Sadick Research Group 10
Large-scale testing (Phase 3)Study completedNCT00948675
What this trial is testing

Study of Participants With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Eli Lilly and Company 361
Not applicableStudy completedNCT04577495
What this trial is testing

Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma

Who this might be right for
ThymomaComputed TomographyStaging+2 more
IRCCS San Raffaele 50
Not applicableStudy completedNCT03714139
What this trial is testing

Immediate Loading a Histological Study

Who this might be right for
Edentulous Alveolar Ridge
ARDEC Academy 12
Not applicableEnded earlyNCT01856036
What this trial is testing

Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers

Who this might be right for
Breast Cancer
Saint John's Cancer Institute 2
Large-scale testing (Phase 3)Ended earlyNCT00596830
What this trial is testing

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Who this might be right for
Carcinoma, Squamous CellCarcinoma, AdenosquamousCarcinoma, Large Cell+1 more
Pfizer 681
Not applicableStudy completedNCT01533311
What this trial is testing

Prevalence and Characteristics of Nonpolypoid Colorectal Neoplasms - A Chinese Cohort Study

Who this might be right for
Nonpolypoid Colorectal Neoplasms(NP-CRN)
Shanghai Jiao Tong University School of Medicine 1,342
Not applicableStudy completedNCT00902434
What this trial is testing

Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era

Who this might be right for
Non-Hodgkin's Lymphoma
Oncology Specialists, S.C. 50
Not applicableEnded earlyNCT00491621
What this trial is testing

Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer

Who this might be right for
Kidney Neoplasms
Centre Hospitalier Universitaire de Saint Etienne 74
Not applicableStudy completedNCT05295537
What this trial is testing

Percutaneous Versus Endoscopic Ultrasound-guided Liver Biopsy (PEREUS)

Who this might be right for
Liver Diseases
Hospital Clinico Universitario de Santiago 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639219
What this trial is testing

T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

Who this might be right for
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
AstraZeneca 102
Not applicableUnknownNCT00510432
What this trial is testing

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients

Who this might be right for
Allergy
Johann Wolfgang Goethe University Hospital 500
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Not applicableStudy completedNCT00922025
What this trial is testing

Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 186
Testing effectiveness (Phase 2)Study completedNCT01693783
What this trial is testing

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Squamous Cell CarcinomaHuman Papillomavirus Infection+3 more
National Cancer Institute (NCI) 42
Next Page